CNTA logo
CNTA NASDAQ GB

Centessa Pharmaceuticals plc - American Depositary Shares

Healthcare · Biotechnology Website · IPO May 2021
$39.69
▼ $-0.17 (-0.43%)
Vol 3.6M
4
Quality Score
fail
Mkt Cap
$3.4B
ROE
-67.7%
D/E
36.41
Beta
1.53
52W
$10–$31

Wall Street Consensus

19 analysts · Apr 2026
6
Strong Buy
8
Buy
5
Hold
0
Sell
0
Strong Sell
73.7%
Buy Rating

Price Chart

Similar Stocks

ROIV
Roivant Sciences Ltd
$15.1B
KNSA
Kiniksa Pharmaceuticals International PLC
P/E 87.0
$3.1B
IMCR
Immunocore Holdings PLC
$1.8B
CMPS
Compass Pathways PLC
$662.4M
AUTL
Autolus Therapeutics PLC
$524.3M
BCYC
Bicycle Therapeutics PLC
$471.3M

Earnings

Beat rate: 20.0%
Next Report May 12, 2026
EPS Estimate: $-0.41
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.41 — —
Dec 2025 $-0.39 $-0.48 $-0.09
Sep 2025 $-0.40 $-0.41 $-0.01
Jun 2025 $-0.35 $-0.38 $-0.03

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -56.6% -56.4% -56.6% -56.6% -67.7% -67.7%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 31.76 31.88 31.76 31.76 36.41 36.41
Current Ratio 10.12 10.00 10.12 10.12 10.56 10.56

Key Ratios

ROA (TTM)
-47.5%
P/B
5.5
EPS (TTM)
$-1.82
CF/Share
$-1.64
52W High
$30.58
52W Low
$9.60
$9.60 52-Week Range $30.58

How does CNTA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CNTA AAPG ABEO ABOS ABP

CNTA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
5.5
▲ 124% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CNTA profitability vs Biotechnology peers

ROE
-67.7%
▼ 1% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-47.5%
▼ 2% below peers (-46.7%)
vs Peers
vs Industry
In line

CNTA financial health vs Biotechnology peers

D/E ratio
36.4
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
10.6
▲ 138% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.5
▲ 58% above peers (1.0)
vs Peers
vs Industry
More volatile

CNTA fundamentals radar

CNTA Peer median Industry

CNTA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CNTA vs peers: key metrics

Latest News

Options Traders Pick Up Pharma Stock After Eli Lilly Buyout
Yahoo Finance · Apr 02
Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
Yahoo Finance · Apr 01